|drug3475||Transthoracic echocardiogram (TTE) Wiki||1.00|
|drug489||Blood samples (collection of 5 mL of blood in a dry tube) Wiki||1.00|
|drug2154||Nasopharyngeal swabs Wiki||0.71|
|D018754||Ventricular Dysfunction NIH||0.50|
|D001145||Arrhythmias, Cardiac NIH||0.50|
|D018487||Ventricular Dysfunction, Left NIH||0.50|
There is one clinical trial.
COLUMBIA CARDS is a pilot study to understand how COVID-19 affects the heart. It is known that COVID-19 can affect the heart in different ways. COLUMBIA CARDS is studying why some COVID-19 survivors develop clinical conditions such as heart inflammation, fluid buildup, blood clots, and other cardiac problems during or after their COVID-19 illness, and why other ones do not. In this study, we will use cardiovascular magnetic resonance (CMR) and transthoracic echocardiography (TTE) to better understand the impact of COVID-19 on the heart.
Description: Percentage of myocardium demonstrating late gadolinium enhancement by cardiac magnetic resonance (CMR) imaging, determined using Circle cvi42 software.Measure: Percentage of myocardium demonstrating late gadolinium enhancement Time: Up to 2 hours
Description: Extracellular volume fraction measured by CMR imaging. ECV determined using Circle cvi42 software and using formula ECV = (1-hematocrit) × (Δ(1/T1myocardium)/Δ(1/T1blood)).Measure: Extracellular Volume (ECV) Fraction Time: Up to 2 hours
Description: Left ventricular ejection fraction (percent ejection fraction) by CMR imaging and determined using Circle cvi42 software.Measure: Left Ventricular Ejection Fraction Time: Up to 2 hours
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports